The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 89, Issue 2, Pages 165-176
Publisher
Wiley
Online
2012-06-13
DOI
10.1111/j.1600-0609.2012.01804.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom
- (2011) C. R. M. Hay et al. BLOOD
- Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII
- (2011) Kamilla Swiech et al. BMC BIOTECHNOLOGY
- The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products
- (2011) S. M. A. ZAMAN et al. HAEMOPHILIA
- Patient and parent preferences for haemophilia A treatments
- (2010) A. F. MOHAMED et al. HAEMOPHILIA
- Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review
- (2010) A. IORIO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Recombinant plasma proteins
- (2010) T. Burnouf VOX SANGUINIS
- Functional roles of the factor VIII B domain
- (2009) S. W. PIPE HAEMOPHILIA
- An improved manufacturing process for Xyntha/ReFacto AF
- (2009) B. KELLEY et al. HAEMOPHILIA
- Cost of care of haemophilia with inhibitors
- (2009) M. N. D. DI MINNO et al. HAEMOPHILIA
- Application of a novel affinity adsorbent for the capture and purification of recombinant Factor VIII compounds
- (2009) Justin T. McCue et al. JOURNAL OF CHROMATOGRAPHY A
- Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies
- (2009) Herbert O. Dichtelmüller et al. TRANSFUSION
- Physicians’ preferences towards coagulation factor concentrates in the treatment of Haemophilia with inhibitors: a discrete choice experiment
- (2008) WC LEE et al. HAEMOPHILIA
- Physiology of the Prion Protein
- (2008) Rafael Linden et al. PHYSIOLOGICAL REVIEWS
- Kinetics of inactivating human parvovirus B19 and porcine parvovirus by dry-heat treatment
- (2008) Johannes Blümel et al. TRANSFUSION
- Prion removal by nanofiltration under different experimental conditions
- (2007) Mikihiro Yunoki et al. BIOLOGICALS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started